PGNewsroom



Introducing our expanded genetic testing menu for pediatric oncology

Published on

September marks Cancer Awareness Month, a time to reflect on the progress made in cancer care and the work still ahead—especially for children and families facing a cancer diagnosis. At PreventionGenetics, we’re proud to introduce our new pediatric oncology genetic testing menu, designed to support precision medicine and family-centered care for childhood cancers.

A tool for informed childhood cancer care

Research shows that up to 18% of pediatric solid tumor patients carry pathogenic germline variants.¹ These variants can influence treatment decisions, guide surveillance strategies, and inform family risk—making genetic testing a critical component of pediatric cancer care.

“Genetic insights are transforming how we approach pediatric oncology,” said Melanie Hayward, Vice President, Genetics, at Exact Sciences. “Our new menu reflects our commitment to ensuring access to critical diagnostic tests for rare, pediatric cancer disorders and helping deliver actionable answers for clinicians and families.”

A comprehensive menu for childhood cancer genetic testing

Our expanded pediatric oncology menu features new solid tumor panels powered by a probeset specifically optimized for oncology, enhancing detection into a broad range of cancers. Alongside these, our trusted hematology panels provide critical diagnostic insight for blood-related conditions. Together, these offerings reflect the latest clinical guidelines and research, supporting comprehensive care across pediatric oncology.

Solid Tumors:

•   Central nervous system and brain cancer

•   Endocrine tumors

•   Neuroblastoma

•   Nevoid basal cell carcinoma

•   Retinoblastoma

•   Sarcomas

•   Wilms tumor

Hematologic and Immunologic Conditions:

•   Hereditary myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML)

•   Inherited bone marrow failure

•   Primary immunodeficiency and malignancy predisposition

“We designed these panels with pediatric oncology in mind—selecting genes that are clinically relevant and actively studied in childhood cancer research,” said Dr. Piper Nicolosi, a lead molecular geneticist at PreventionGenetics. “Our goal is to empower care teams with the insights they need to personalize treatment and support families.”

Backed by Exact Sciences

As part of Exact Sciences, a recognized leader in cancer diagnostics, our lab brings deep expertise and innovation to every test we perform. From streamlined ordering to STAT options and New York State approval, our pediatric oncology menu is built to support clinicians and families at every step.

Learn more

Explore our full pediatric oncology as part of our Cancer Genetics test menu.

 

 

Reference

1. Fiala et al. 2021. PubMed ID: 34308366